News

Dutch-based biopharmaceutical company, Prosensa has raised €23m in new equity financing to advance its portfolio of RNA-modulating therapeutics for the treatment of rare diseases, including Duchenne muscular dystrophy (DMD), Myotonic Dystrophy (DM1) and Huntington's disease (HD). ...

Selventa, a biomarker discovery company, has received US patent entitled Computer-aided Discovery of Biomarker Profiles in Complex Biological Systems. The patent is related to methods and techniques that facilitate discovery of biomarkers and aid in the...

Upsher-Smith Laboratories has launched B-Nexa, a prescription prenatal vitamin for pregnant women who suffer from nausea and vomiting of pregnancy (NVP). B-Nexa is designed with B vitamins and ginger to help calm NVP, also...

The settlement includes $10 million in costs and fees, and will total between $21.8 million and $37 million, depending upon the number of eligible claims. The plaintiffs’ lawyer Mike Peerless said up to 2,000 Canadians...

UK-based pharmaceutical company BTG has received US Food and Drug Adminsitration (FDA) approval for its Voraxaze medication, which is used to treat patients suffering from toxic levels of methotrexate due to kidney failure. The basis of the approval...

Approval for AstraZeneca and Bristol-Myers Squibb's diabetes drug dapagliflozin has been rejected by the US Food and Drug Administration. The FDA issued the rejection in its complete response letter, stating that additional clinical data...

Elderly people with dementia are three times more likely to have an injurious fall if they take antidepressants, according to research published in the British Journal of Clinical Pharmacology. The association with falls can...